Healthcare

MediXall Group (OTCQB: MDXL) CEO Interview Series

January 30, 2019 The Wall Street Analyzer Comments Off

MediXall Group (OTCQB: MDXL) CEO: Michael Swartz SVP Marketing: Vincent Caputo THIS INTERVIEW HAS EXPIRED

Citius Pharmaceuticals to Present at NobleCon15 Investor Conference

January 26, 2019 The Wall Street Analyzer Comments Off

Noble Capital Markets’ Fifteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 28th at 10:00am Eastern Standard Timein Studio 2. […]

Generex Biotechnology (OTC: GNBT) CEO Interview

January 22, 2019 The Wall Street Analyzer Comments Off

Generex Biotechnology (OTC: GNBT) CEO: Joe Moscato THIS INTERVIEW HAS EXPIRED

Marker Therapeutics (NASDAQ: MRKR) CEO and President: Peter Hoang

January 16, 2019 The Wall Street Analyzer Comments Off

Marker Therapeutics (NASDAQ: MRKR) CEO and President: Peter Hoang THIS INTERVIEW HAS EXPIRED

DURECT Corporation (NASDAQ:DRRX) President and CEO: Jim Brown

December 4, 2018 The Wall Street Analyzer Comments Off

DURECT Corporation (NASDAQ:DRRX) President and CEO: Jim Brown THIS INTERVIEW HAS EXPIRED

Albireo Pharma, Inc. (Nasdaq: ALBO) CEO INTERVIEW

December 3, 2018 The Wall Street Analyzer Comments Off

Albireo Pharma, Inc. (Nasdaq: ALBO) CEO: Ron Cooper THIS INTERVIEW HAS EXPIRED

Eidos Therapeutics, Inc. (Nasdaq:EIDX) Management Interview

November 16, 2018 The Wall Street Analyzer Comments Off

Eidos Therapeutics, Inc. (Nasdaq:EIDX) President and CMO: Jonathan Fox CBO: Cameron Turtle THIS INTERVIEW HAS EXPIRED

Tyme Technologies (NASDAQ: TYME) Management Interview

November 12, 2018 The Wall Street Analyzer Comments Off

Tyme Technologies (NASDAQ: TYME) Chief Scientific Affairs Officer: Dr. Jonathan Eckard THIS INTERVIEW HAS EXPIRED, PLEASE CHECK OUT OUR FEATURED INTERVIEW SECTION FOR OTHER EXCITING STORIES.

Valeritas Reports Record Revenue for the Third Quarter 2018

November 9, 2018 The Wall Street Analyzer Comments Off

Company’s Third Consecutive Quarter with Greater than 30% Year-Over-Year Revenue Growth […]

Vaccinex, Inc. (Nasdaq:VCNX) Interview with CEO Maurice Zauderer

October 9, 2018 The Wall Street Analyzer Comments Off

Vaccinex, Inc. (Nasdaq:VCNX) CEO: Maurice Zauderer THIS INTERVIEW HAS EXPIRED

Featured Interviews

ClearBlue Technologies International (TSXV: CBLU)(OTC: CBUTF)

June 28, 2022 0

INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street, this is Juan Costello, Senior Analyst with the Wall Street Analyzer. Joining us today is Miriam Tuerk, CEO and Co-Founder at Clear Blue Technologies International. The company […]

CEO Interviews

C-COM Satellite Systems Inc. (TSXV: CMI) (OTCQB: CYSNF)

April 19, 2022 0

INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street, this is Juan Costello, Senior Analyst with the Wall Street Analyzer. Joining us today is Leslie Klein, President and CEO at C-COM Satellite Systems. The Company trades […]

Featured Interviews

Knightscope, Inc (NASDAQ: KSCP)

March 10, 2022 0

ABOUT: Knightscope was launched in April 2013 by William Santana Li and Stacy Dean Stephens. The Company was formed in response to the tragic shootings at Sandy Hook, the Boston bombings, and the attacks of […]